投稿日時:12/02/14 4:41 視聴回数:476回
カテゴリ:
ビジネス全般
タグ:
GNOM 
ESTE 
CPRX 
Nasdaq:GNOM 
Amex:ESTE 
Nasdaq:CPRX 
クリエイティブ・コモンズ・ライセンス:
表示-非営利 2.1 日本
Complete Genomics Inc- GNOM - reported that it has been selected by Mayo Clinic’s Center for Individualized Medicine to provide outsourced whole human genome sequencing. On its third quarter fiscal 2012, Earthstone Energy Inc - ESTE - posted net income of $1,152,000, compared to $74,000 in the same period the prior year. Catalyst Pharmaceutical Partners Inc - CPRX - reported that the European Commission has granted orphan medicinal product designation for the company’s investigational-drug, CPP-115, for the treatment of West Syndrome (infantile spasms).
*********************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).